Kalaris Therapeutics Inc (KLRS) — institutional ownership

56 funds reported holding Kalaris Therapeutics Inc in their latest 13F filings, worth $75.8M in total (CUSIP 482929106).

Largest holders

1. Samsara BioCapital, LLC — $52.4M
2. RTW INVESTMENTS, LP — $5.29M
3. VANGUARD GROUP INC — $2.47M
4. Alyeska Investment Group, L.P. — $2.33M
5. Siren, L.L.C. — $1.77M
6. VANGUARD CAPITAL MANAGEMENT LLC — $1.62M
7. Ikarian Capital, LLC — $1.47M
8. UBS Group AG (UBS) — $1.07M
9. RENAISSANCE TECHNOLOGIES LLC — $608K
10. MARSHALL WACE, LLP — $567K

Famous investors holding it

• Renaissance Technologies portfolio (Renaissance Technologies)
• Ken Griffin portfolio (Citadel Advisors)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at Kalaris Therapeutics Inc

Who owns the most KLRS stock?

The largest institutional holders in the latest 13F filings are Samsara BioCapital, LLC ($52.4M), RTW INVESTMENTS, LP ($5.29M), VANGUARD GROUP INC ($2.47M).

How many funds own KLRS?

56 funds reported holding it, worth $75.8M in total.